Low-Dose Naltrexone Combined With Bupropion to Stop Smoking With Less Weight Gain
Status:
Completed
Trial end date:
2005-12-01
Target enrollment:
Participant gender:
Summary
This study will test a combination of the drugs naltrexone and bupropion with
weight-concerned smokers to investigate whether or not this combination of drugs improves
smoking cessation quit rates and minimizes post quit weight gain.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Yale University
Collaborator:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)